Scientists Uncover Cancer-Fighting Power of Popular Fatty Liver Drug
Resmetirom may help prevent or suppress fatty liver-related liver cancer by improving metabolism and reducing activity in the…
Researchers develop pH and redox-sensitive systems to reduce immunotherapy toxicity
Although cancer immunotherapy has transformed treatment by harnessing the immune system to eliminate tumors, only a small subset…
Multi-center research initiative aims to improve glioblastoma patient outcomes
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center are part of a new multi-institution research effort aimed at improving…
Breakthrough Bowel Cancer Trial Leaves Patients Cancer-Free for Nearly 3 Years
Researchers report encouraging long-term results from an experimental treatment approach that rethinks the timing of cancer therapy. By…
Targeting glutamine metabolism enhances CAR-macrophage cancer therapy
Tumor-associated macrophages (TAMs) within the tumor microenvironment (TME) exhibit significant metabolic dysregulation, which impairs their antitumor function. Specifically,…
New roadmap links liver cancer biology to immunotherapy and precision medicine
A new review from the Icahn School of Medicine at Mount Sinai and the Hospital Clínic de Barcelona…
Mitochondrial activity keeps dendritic cells ready to fight disease
Researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) show that active mitochondria maintain dendritic cells,…
New biomarker predicts prognosis and treatment response in colorectal cancer
Determining the presence of a protein in non-tumor cells within the cancer microenvironment could be one of the keys to establishing prognosis…
Nanomedicine offers targeted solutions for breast cancer treatment
Breast cancer (BCA) is one of the most common cancers worldwide, with high mortality and morbidity in women.…
Study explores racial differences in gastric cancer immunotherapy outcomes
Advanced gastric cancer remains one of the deadliest malignancies, with a 5-year overall survival rate below 10%. In…
New guidance aims to standardize tumor mutational burden in cancer
Immune checkpoint inhibitors have transformed cancer care, yet only a minority of patients respond to monotherapy, and immune-related…
Blood pressure drug boosts effectiveness of cancer therapy
In a new Dartmouth Cancer Center (DCC) study led by clinical researcher Tyler J. Curiel, MD, MPH, FACP,…